作者
黄宇婷,孙权权,王禹都
文章摘要
血管疾病是全球范围内的重大健康问题,血管修复对于改善患者预后至关重要。内皮祖细胞捕获支架作为一种新兴的血管内治疗策略,在血管修复领域展现出巨大潜力。本文综述了内皮祖细胞的生物学特性,内皮祖细胞捕获支架的设计原理与类型及其临床研究现状。
文章关键词
内皮祖细胞;支架;血管修复
参考文献
[1] Tommaso G,Alberto P,Ciro I,et al.Predictors of stent thrombosis and their implications for clinical practice[J].Nat Rev Cardiol, 2019,16(4):243-256.
[2] Masahito N,Shinichi O,Masanori S,et al.Prevention of neointimal hyperplasia induced by an endovascular stent via intravenous infusion of mesenchymal stem cells[J].J Neurosurg,2019,133(6):1-13.
[3] Lan H,Wang Y,Yin T,et al.Progress and prospects of endothelial progenitor cell therapy in coronary stent implantation[J].J Biomed Mater Res B Appl Biomater,2016,104(6):1237-47.
[4] Yan F,Liu X,Ding H,et al.Paracrine mechanisms of endothelial progenitor cells in vascular repair[J].Acta Histochem,2022, 124(1):151833-151833.
[5] Khan W,Farah S,Domb A J,et al.Drug eluting stents:developments and current status[J].J Control Release,2012,161:703–12.
[6] Asahara T,Murohara T,Sullivan A,et al.Isolation of putative progenitor endothelial cells for angiogenesis[J].Science.1997,275(5302):964-7.
[7] Wang X,Wang R,Jiang L,et al.Endothelial repair by stem and progenitor cells[J].J Mol Cell Cardiol,2022,163133-146.
[8] Medina R J,Barber C L,Sabatier F,et al.Endothelial progenitors:A consensus statement on nomenclature[J].Stem Cells Transl Med, 2017,6(5):1316–1320.
[9] Doris S,Renate H,Caterina S,et al.Cytokine-like 1 is a novel proangiogenic factor secreted by and mediating functions of endothelial progenitor cells[J].Circ Res,2019,124(2):243-255.
[10] Guan M,Chen M,Li H,et al.Biological properties of bone marrow-derived early and late endothelial progenitor cells in different culture media[J].Mol Med Rep,2013,8(6):1722-8.
[11] Keighron C,Lyons J C,Creane M,et al.Recent advances in endothelial progenitor cells toward their use in clinical translation[J].Front Med,2018,5:354.
[12] Minami Y,Nakajima T,Ikutomi M,et al.Angiogenic potential of early and late outgrowth endothelial progenitor cells is dependent on the time of emergence[J].Int J Cardiol,2015,186:305-314.
[13] Park K,Kang N S,Kim H D,et al.Late endothelial progenitor cell-capture stents with CD146 antibody and nanostructure reduce in-stent restenosis and thrombosis[J].Acta Biomater,2020,111(prepublish):91-101.
[14] Tan A,Goh D,Farhatnia Y,et al.An anti-CD34 antibody-functionalized clinical-grade POSS-PCU nanocomposite polymer for cardiovascular stent coating applications:a preliminary assessment of endothelial progenitor cell capture and hemocompatibility[J].PLoS One,2017,8(10):e77112.
[15] Fu G,Yu Z,Chen Y,et al.Direct Adsorption of anti-CD34 antibodies on the nano-porous stent surface to enhance endothelialization[J]. Acta Cardiol Sin,2016,32(3):273-80.
[16] Sethi R,Lee C.Endothelial progenitor cell capture stent:safety and effectiveness[J].J Interv Cardiol,2012,25(5):493-500.
[17] Hassanpour M,Salybekov A A,Kobayashi S,et al.CD34 positive cells as endothelial progenitor cells in biology and medicine[J].Front Cell Dev Biol,2023,11:1128134.
[18] van Beusekom H M,ErtaşG,Sorop O,et al.The Genous™endothelial progenitor cell capture stent accelerates stent re-endothelialization but does not affect intimal hyperplasia in porcine coronary arteries[J].Catheter Cardiovasc Interv.2012,79(2):231-42.
[19] Sun A,Huang X,Jiao Y,et al.Construction of biological factor-coated stent and its effect on promoting endothelialization[J].Mater Sci Eng C Mater Biol Appl,2021,122:111943-111943.
[20] Huang C,Zheng X,Mei H,et al.Rescuing impaired re-endothelialization of drug eluting stents using the hepatocyte growth factor[J].Ann Vasc Surg,2016,36:273-282.
[21] Chen W,Yang M,Bai J,et al.Exosome-modified tissue engineered blood vessel for endothelial progenitor cell capture and targeted siRNA delivery[J].Macromol Biosci,2018,18(2).
[22] Deng J,Yuan S,Li X,et al.Heparin/DNA aptamer co-assembled multifunctional catecholamine coating for EPC capture and improved hemocompatibility of vascular devices[J].Mater Sci Eng C Mater Biol Appl,2017,79:305-314.
[23] Lu T,Sakuma M,Sohma R,et al.Mobilization of endothelial progenitor cells after implantation of CD34 antibody-covered sirolimus-eluting COMBO®stent:assessment with EPC colony-forming assay[J].Heart Vessels,2024,(prepublish):1-11.
[24] Aoki J,Serruys P W,van Beusekom H,et al.Endothelial progenitor cell capture by stents coated with antibody against CD34:the HEALING-FIM(Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man)Registry[J].J Am Coll Cardiol,2005,45(10):1574-9.
[25] Co M,Tay E,Lee H C,et al.Use of endothelial progenitor cell capture stent(Genous Bio-Engineered R Stent)during primary percutaneous coronary intervention in acute myocardial infarction:intermediate-to long-term clinical follow-up[J].Am Heart J,2008, 155(1):128-32.
Full Text:
DOI